Test ID RISAP Risankizumab Quantitation with Antibodies, Serum
Specimen Required
Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1.5 mL
Collection Instructions:
1. Draw blood immediately before next scheduled dose (trough specimen).
2. Within 2 hours of collection, centrifuge, and aliquot serum into a plastic vial.
Reporting Name
Risankizumab QN with Antibodies, SSpecimen Type
SerumSpecimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 28 days |
| Frozen | 28 days |
Report Available
2 to 9 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| RISAP | Risankizumab QN with Antibodies, S | 105194-5 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 621304 | Risankizumab, S | 105041-8 |
| 621769 | Risankizumab Ab, S | 105195-2 |
| 621812 | RISAB Interpretation | 59462-2 |
Forms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Gastroenterology and Hepatology Test Request (T728)
-Therapeutics Test Request (T831)
Useful For
Evaluation of patients with limited primary (initial) response to or secondary loss of response to risankizumab
Day(s) Performed
Weekly
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80299
82397
Specimen Minimum Volume
0.75 mL
Reference Values
RISANKIZUMAB QUANTITATION:
Risankizumab lower limit of quantitation =1.0 mcg/mL
RISANKIZUMAB ANTIBODIES:
Antibodies to risankizumab: <20.0 ng/mL
Method Name
RISA: Liquid Chromatography Mass Spectrometry (LC-MS)
RISAB: Electrochemiluminescent-Bridging Immunoassay (ECLIA)
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| RISA | Risankizumab, S | Yes | Yes |
| RISAB | Risankizumab Ab, S | No | Yes |
Testing Algorithm
For information see Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm.